ATC Group: A02AB01 Aluminium hydroxide

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of A02AB01 in the ATC hierarchy

Level
Code
Title
1
A
Alimentary tract and metabolism
2
A02
Drugs for acid related disorders
3
A02A
Antacids
4
A02AB
Aluminium compounds
5
A02AB01
Aluminium hydroxide

Active ingredients in A02AB01

Active Ingredient
Description

Aluminium hydroxide is a slow-acting antacid. It is used to provide symptomatic relief in gastric hyperacidity. In addition, the antipeptic and demulcent activity of aluminium hydroxide helps to protect inflamed gastric mucosa against further irritation by gastric secretions.

Related product monographs

Title
Information Source
Document Type
 
ALU-CAP Capsules
Medicines & Healthcare Products Regulatory Agency (GB)
MPI, EU: SmPC
MAALOX Oral suspension
Health Products Regulatory Authority (IE)
MPI, EU: SmPC

Medicines in this ATC group

Austria (AT)

Brazil (BR)

Cyprus (CY)

Estonia (EE)

France (FR)

Hong Kong (HK)

Ireland (IE)

Japan (JP)

Lithuania (LT)

Malta (MT)

Netherlands (NL)

Poland (PL)

Singapore (SG)

South Africa (ZA)

Tunisia (TN)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

Move up one level Go to ATC index
⇈